Life quality of the patient with gout after autologous bone marrow cell treatment
- Authors: Khadartsev A.A.1, Ivanov D.V.1, Shatalov A.V.2, Potapov I.V.2
-
Affiliations:
- State Research Institute of New Medical Technologies
- Biostem Ltd. Co.
- Issue: Vol 1, No 3 (2006)
- Pages: 73-75
- Section: Clinical experience
- URL: https://genescells.ru/2313-1829/article/view/279983
- DOI: https://doi.org/10.23868/gc279983
- ID: 279983
Cite item
Open Access
Access granted
Abstract
Standard treatment modalities of patients with chronic gout using xanthine oxidase inhibitors (allopurinol) and prostaglandin inhibitors (nonsteroid antiinflammatory drugs) lose their efficacy gradually. The given clinical observation demonstrates positive treatment results after having used autologous cells of bone marrow in a patient with gout.
Keywords
Full Text
About the authors
A. A. Khadartsev
State Research Institute of New Medical Technologies
Author for correspondence.
Email: Doctor_Ivanov@rambler.ru
Russian Federation, Moskow
D. V. Ivanov
State Research Institute of New Medical Technologies
Email: Doctor_Ivanov@rambler.ru
Russian Federation, Moskow
A. V. Shatalov
Biostem Ltd. Co.
Email: Doctor_Ivanov@rambler.ru
Russian Federation, Moskow
I. V. Potapov
Biostem Ltd. Co.
Email: Doctor_Ivanov@rambler.ru
Russian Federation, Moskow
References
Supplementary files
